CAR-T Labels Take Different Approaches To Malignancy Safety Updates

 
• By Sue Sutter
  
One different
One of the six CAR-T therapies has added the risk of secondary malignancies to its label's boxed warning. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies